Mineralocorticoid Receptor Antagonists, Blood Pressure, and Drug Discontinuation.

Pedro Marques,Joana Tender Vieira,Luís Flores, Ana Ribeiro,Ana Faceira

JACC: Heart Failure（2020）

Cited 0|Views8

No score

Abstract

Serenelli et al. ([1][1]) investigated the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Data from 2 randomized clinical trials using MRAs were compared with those with

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined